(Q46516144)

English

Induction of leukemia-specific CD8+ cytotoxic T cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-alpha

scientific article published on 20 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Induction of leukemia-specific CD8+ cytotoxic T cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-alpha (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Aurore Saudemont

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

object named as

Bruno Quesnel

5

0 references

author name string

Selim Corm

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Thomas Wickham

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Dominique Hetuin

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

publication date

20 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

950-959

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Dendritic cell-based immunotherapy for the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Dendritic cells in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Efficient generation of antileukemic autologous T cells by short-term culture and gamma-irradiation of myeloid leukemic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

TNF-alpha receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Targeting adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Gamma-irradiation enhances transgene expression in leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Short-term culture of myeloid leukemic cells allows efficient transduction by adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Influence of immunosuppressive drugs on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Rapamycin impairs antigen uptake of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.016

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.12.016

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15922966

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46516144&oldid=2123028396"